NAT10 and familial pancreatic carcinoma: Xu et al. [84] collected genomic data from pancreatic cancer tissues and constructed NAT10 subgroup phenotypes to assess the association between NAT10 levels and clinicopathological characteristics of patients with pancreatic cancer.